1 Lund Group, BRIC Research Groups, BRIC, Københavns Universitet2 Computational and RNA Biology, Department of Biology, Faculty of Science, Københavns Universitet3 Memorial Sloan-Kettering Cancer Center4 Lund Group, BRIC, Faculty of Health and Medical Sciences, Københavns Universitet5 Lund Group, BRIC Research Groups, BRIC, Københavns Universitet6 Memorial Sloan-Kettering Cancer Center7 Lund Group, BRIC, Faculty of Health and Medical Sciences, Københavns Universitet8 Computational and RNA Biology, Department of Biology, Faculty of Science, Københavns Universitet
ABSTRACT: BACKGROUND: MicroRNAs (miRNAs) are well recognized as gene regulators and have been implicated in the regulation of development as well as human diseases. miR-143 is located at a fragile site on chromosome 5 frequently deleted in cancer, and has been reported to be down-regulated in several cancers including colon cancer. METHODS: To gain insight into the role of miR-143 in colon cancer, we used a microarray-based approach in combination with seed site enrichment analysis to identify miR-143 targets. RESULTS: As expected, transcripts down-regulated upon miR-143 overexpression had a significant enrichment of miR-143 seed sites in their 3' UTRs. Here we report the identification of Hexokinase 2 (HK2) as a direct target of miR-143. We show that re-introduction of miR-143 in the colon cancer cell line DLD-1 results in a decreased lactate secretion. CONCLUSION: We have identified and validated HK2 as a miR-143 target. Furthermore, our results indicate that miR-143 mediated down-regulation of HK2 affects glucose metabolism in colon cancer cells. We hypothesize that loss of miR-143-mediated repression of HK2 can promote glucose metabolism in cancer cells, contributing to the shift towards aerobic glycolysis observed in many tumors.